Previous Close | 61.71 |
Open | 61.75 |
Bid | 0.00 x 900 |
Ask | 0.00 x 1000 |
Day's Range | 61.75 - 62.31 |
52 Week Range | 58.20 - 79.45 |
Volume | |
Avg. Volume | 12,646 |
Net Assets | 96.99M |
NAV | 62.08 |
PE Ratio (TTM) | N/A |
Yield | 2.04% |
YTD Daily Total Return | -15.01% |
Beta (5Y Monthly) | 0.86 |
Expense Ratio (net) | 0.30% |
Inception Date | 2016-10-24 |
The allegations are the latest against biotech wizard Serhat Gumrukcu who was indicted in a murder-for-hire case in recent months.
LOS ANGELES, July 01, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB)—In recent days, Enochian BioSciences (the Company) has conducted a rigorous internal review of scientific data to give partners and investors a clear understanding of the Company’s pipelines. The results of this investigation verified key primary data for the Company’s HIV and cancer pipelines. The investigation also verified the primary data from an animal model with intravenous delivery of a potential treatment for COVID-19 that was